Discovery and resupply of pharmacologically active plant-derived natural products: A review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Actis-Goretta, 2012, Elucidation of (−)-epicatechin metabolites after ingestion of chocolate by healthy humans, Free Radic. Biol. Med., 53, 787, 10.1016/j.freeradbiomed.2012.05.023
Adams, 2012, Epilepsy in the Renaissance: a survey of remedies from 16th and 17th century German herbals, J. Ethnopharmacol., 143, 1, 10.1016/j.jep.2012.06.010
Adekenov, 1982, Arglabin, a new sesquiterpene lactone from Artemisia glabella, 655
Afolayan, 2004, In vitro propagation: a biotechnological tool capable of solving the problem of medicinal plants decimation in South Africa, Afr. J. Biotechnol., 3, 683
Agarwal, 2014, Use of in vitro bioassays for assessing botanicals, Curr. Opin. Biotechnol., 25, 39, 10.1016/j.copbio.2013.08.010
Ager, 2011, Route and process selection, 17
Aggarwal, 2011, Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach, Curr. Drug Targets, 12, 1595, 10.2174/138945011798109464
Ajikumar, 2010, Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli, Science, 330, 70, 10.1126/science.1191652
Akao, 2002, Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury, Planta Med., 68, 714, 10.1055/s-2002-33792
Alali, 2005, New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid, J. Nat. Prod., 68, 173, 10.1021/np0496587
Alali, 2008, Colchicinoids from Colchicum crocifolium Boiss.: a case study in dereplication strategies for (−)-colchicine and related analogues using LC–MS and LC–PDA techniques, Phytochem. Anal., 19, 385, 10.1002/pca.1060
Alkhalfioui, 2009, From purified GPCRs to drug discovery: the promise of protein-based methodologies, Curr. Opin. Pharmacol., 9, 629, 10.1016/j.coph.2009.04.002
Alqahtani, 2013, Experimental models for predicting drug absorption and metabolism, Expert Opin. Drug Metab. Toxicol., 9, 1241, 10.1517/17425255.2013.802772
Amirkia, 2014, Alkaloids as drug leads — a predictive structural and biodiversity-based analysis, Phytochem. Lett., 10, xlviii, 10.1016/j.phytol.2014.06.015
Anastas, 1998
Andraos, 2005, Unification of reaction metrics for green chemistry: applications to reaction analysis, Org. Process Res. Dev., 9, 149, 10.1021/op049803n
Andraos, 2009, Global green chemistry metrics analysis algorithm and spreadsheets: evaluation of the material efficiency performances of synthesis plans for oseltamivir phosphate (Tamiflu) as a test case, Org. Process Res. Dev., 13, 161, 10.1021/op800157z
Andraos, 2007, On the use of “Green” metrics in the undergraduate organic chemistry lecture and lab to assess the mass efficiency of organic reactions, J. Chem. Educ., 84, 1004, 10.1021/ed084p1004
Anterola, 2009, Production of taxa-4(5),11(12)-diene by transgenic Physcomitrella patens, Transgenic Res., 18, 655, 10.1007/s11248-009-9252-5
Appendino, 2014, Omnia praeclara rara. The quest for ingenol heats up, Angew. Chem. Int. Ed. Engl., 53, 927, 10.1002/anie.201308281
Appendino, 1999, An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris, J. Nat. Prod., 62, 76, 10.1021/np980218n
Appendino, 2009, Genepolide, a sesterpene gamma-lactone with a novel carbon skeleton from mountain wormwood (Artemisia umbelliformis), J. Nat. Prod., 72, 340, 10.1021/np800468m
Appendino, 2010, 3.08 — Natural products drug discovery, 205
Arora, 2010, Emerging trends in medicinal plant biotechnology, 1
Atanasov, 2013, Polyacetylenes from Notopterygium incisum — new selective partial agonists of peroxisome proliferator-activated receptor-gamma, PLoS One, 8, e61755, 10.1371/journal.pone.0061755
Atanasov, 2013, Honokiol: a non-adipogenic PPARgamma agonist from nature, Biochim. Biophys. Acta, 1830, 4813, 10.1016/j.bbagen.2013.06.021
Atkinson, 2004, In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production, J. Nutr., 134, 596, 10.1093/jn/134.3.596
Baird, 2014, Monitoring Keap1-Nrf2 interactions in single live cells, Biotechnol. Adv., 32, 1133, 10.1016/j.biotechadv.2014.03.004
Balunas, 2006, Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay, J. Nat. Prod., 69, 700, 10.1021/np050513p
Barbosa, 2012, Selecting Medicinal Plants for Development of Phytomedicine and Use in Primary Health Care, Bioactive Compounds in Phytomedicine
Barton, 1962, Phenol oxidation and biosynthesis. V. Synthesis of galanthamine, J. Chem. Soc., 806, 10.1039/jr9620000806
Bauer, 1994, Chinese drugs as a source of new drug materials in western medicine, Pharm. Unserer Zeit, 23, 291, 10.1002/pauz.19940230507
Baumgartner, 2010, Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-d-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor, J. Nat. Prod., 73, 1578, 10.1021/np100258e
Baxendale, 2006, A flow process for the multi-step synthesis of the alkaloid natural product oxomaritidine: a new paradigm for molecular assembly, Chem. Commun. (Camb.), 2566, 10.1039/b600382f
Baxendale, 2006, Preparation of the neolignan natural product grossamide by a continuous-flow process, Synlett, 427
Besumbes, 2004, Metabolic engineering of isoprenoid biosynthesis in Arabidopsis for the production of taxadiene, the first committed precursor of Taxol, Biotechnol. Bioeng., 88, 168, 10.1002/bit.20237
Beutler, 2009, Natural products as a foundation for drug discovery, Curr. Protoc. Pharmacol., 46, 10.1002/0471141755.ph0911s46
Bilyk, 1984, Varietal differences in distribution of quercetin and kaempferol in onion (Allium cepa L.) tissue, J. Agric. Food Chem., 32, 274, 10.1021/jf00122a024
Blazevic, 2014, Indirubin-3′-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration, Cardiovasc. Res., 101, 522, 10.1093/cvr/cvt339
Bohlin, 2010, Natural products in modern life science, Phytochem. Rev., 9, 279, 10.1007/s11101-009-9160-6
Bohr, 1997, Inkulturnahme von bisher aus Wildsammlungen stammenden Wirkstoffpflanzen, 10, 37
Bonfill, 2013, Production and genetic engineering of terpenoids production in plant cell and organ cultures, 2761
Booker-Milburn, 2012, Flow chemistry: a light touch to a deadly problem, Nat. Chem., 4, 433, 10.1038/nchem.1356
Borchardt, 2002, The beginnings of drug therapy: ancient Mesopotamian medicine, Drug News Perspect., 15, 187, 10.1358/dnp.2002.15.3.840015
Bowey, 2003, Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats, Food Chem. Toxicol., 41, 631, 10.1016/S0278-6915(02)00324-1
Brantner, 2003, Crown gall — a plant tumour with biological activities, Phytother. Res., 17, 385, 10.1002/ptr.1283
Breslow, 1972, Centenary Lecture. Biomimetic chemistry, Chem. Soc. Rev., 1, 553, 10.1039/cs9720100553
Brusotti, 2014, Isolation and characterization of bioactive compounds from plant resources: the role of analysis in the ethnopharmacological approach, J. Pharm. Biomed. Anal., 87, 218, 10.1016/j.jpba.2013.03.007
Bucar, 2013, Natural product isolation — how to get from biological material to pure compounds, Nat. Prod. Rep., 30, 525, 10.1039/c3np20106f
Bulger, 2008, Recent advances in biomimetic natural product synthesis, Nat. Prod. Rep., 25, 254, 10.1039/b705909b
Burton, 2014, Emerging R and D law: the Nagoya Protocol and its implications for researchers, ACS Chem. Biol., 9, 588, 10.1021/cb500045t
Butler, 2004, The role of natural product chemistry in drug discovery, J. Nat. Prod., 67, 2141, 10.1021/np040106y
Butler, 2005, Natural products to drugs: natural product derived compounds in clinical trials, Nat. Prod. Rep., 22, 162, 10.1039/b402985m
Butler, 2008, Natural products to drugs: natural product-derived compounds in clinical trials, Nat. Prod. Rep., 25, 475, 10.1039/b514294f
Butler, 2014, Natural product and natural product derived drugs in clinical trials, Nat. Prod. Rep., 31, 1612, 10.1039/C4NP00064A
Butterweck, 2012, What is the best strategy for preclinical testing of botanicals? A critical perspective, Planta Med., 78, 747, 10.1055/s-0031-1298434
Camp, 2012, Drug-like properties: guiding principles for the design of natural product libraries, J. Nat. Prod., 75, 72, 10.1021/np200687v
Cannon, 2012, Is there no end to the total syntheses of strychnine? Lessons learned in strategy and tactics in total synthesis, Angew. Chem. Int. Ed. Engl., 51, 4288, 10.1002/anie.201107385
Canter, 2005, Bringing medicinal plants into cultivation: opportunities and challenges for biotechnology, Trends Biotechnol., 23, 180, 10.1016/j.tibtech.2005.02.002
Caporale, 1995, Chemical ecology: a view from the pharmaceutical industry, Proc. Natl. Acad. Sci. U. S. A., 92, 75, 10.1073/pnas.92.1.75
Cardellina, 1993, A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products extracts, J. Nat. Prod., 56, 1123, 10.1021/np50097a016
Cardoso-Taketa, 2008, Metabolic profiling of the Mexican anxiolytic and sedative plant Galphimia glauca using nuclear magnetic resonance spectroscopy and multivariate data analysis, Planta Med., 74, 1295, 10.1055/s-2008-1074583
Carr, 2008, Streamlined process for the esterification and ketalization of shikimic acid en route to the key precursor for oseltamivir phosphate (Tamiflu), Green Chem., 10, 743, 10.1039/b801582a
Chaturvedi, 2007, Cloning of medicinal plants through tissue culture — a review, Indian J. Exp. Biol., 45, 937
Chemler, 2008, Metabolic engineering for plant natural product biosynthesis in microbes, Curr. Opin. Biotechnol., 19, 597, 10.1016/j.copbio.2008.10.011
Chen, 2012, The active ingredients of Jiang-Zhi-Ning: study of the Nelumbo nucifera alkaloids and their main bioactive metabolites, Molecules, 17, 9855, 10.3390/molecules17089855
Chen, 2013, Metabolic engineering of Escherichia coli: a sustainable industrial platform for bio-based chemical production, Biotechnol. Adv., 31, 1200, 10.1016/j.biotechadv.2013.02.009
Cheng, 2000, Review: drug therapy in Chinese traditional medicine, J. Clin. Pharmacol., 40, 445, 10.1177/00912700022009198
Cho, 2000, Chlorophyllin suppression of lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells, Toxicol. Appl. Pharmacol., 166, 120, 10.1006/taap.2000.8958
Choi, 2014, Metabolomics: what you see is what you extract, Phytochem. Anal., 25, 289, 10.1002/pca.2513
Coan, 2011, Non-stoichiometric inhibition in biochemical high-throughput screening, Expert Opin. Drug Discovery, 6, 405, 10.1517/17460441.2011.561309
Cohen, 2013, Kinase drug discovery — what's next in the field?, ACS Chem. Biol., 8, 96, 10.1021/cb300610s
Coley, 2003, Using ecological criteria to design plant collection strategies for drug discovery, Front. Ecol. Environ., 1, 421, 10.1890/1540-9295(2003)001[0421:UECTDP]2.0.CO;2
Collins, 1998, Removal of polyphenolic compounds from aqueous plant extracts using polyamide minicolumns, Biochem. Mol. Biol. Int., 45, 791
Conrad, 2004, A novel furostanol saponin from Tribulus terrestris of Bulgarian origin, Fitoterapia, 75, 117, 10.1016/j.fitote.2003.09.001
Constable, 2002, Metrics to ‘green chemistry’ — which are the best?, Green Chem., 4, 521, 10.1039/B206169B
Cook, 2014, Detection of toxic monofluoroacetate in Palicourea species, Toxicon, 80, 9, 10.1016/j.toxicon.2013.12.003
Cordell, 2011, Sustainable medicines and global health care, Planta Med., 77, 1129, 10.1055/s-0030-1270731
Corey, 1989
Corson, 2007, Molecular understanding and modern application of traditional medicines: triumphs and trials, Cell, 130, 769, 10.1016/j.cell.2007.08.021
Cos, 2006, Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’, J. Ethnopharmacol., 106, 290, 10.1016/j.jep.2006.04.003
Cragg, 1998, Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development, Med. Res. Rev., 18, 315, 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W
Cragg, 2013, Natural products: a continuing source of novel drug leads, Biochim. Biophys. Acta, 1830, 3670, 10.1016/j.bbagen.2013.02.008
Cragg, 1993, The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents, J. Nat. Prod., 56, 1657, 10.1021/np50100a001
Cragg, 2012, The impact of the United Nations Convention on Biological Diversity on natural products research, Nat. Prod. Rep., 29, 1407, 10.1039/c2np20091k
Creek, 2011, Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction, Anal. Chem., 83, 8703, 10.1021/ac2021823
Curtis, 2008, Ex Vivo Metrics, a preclinical tool in new drug development, J. Transl. Med., 6, 5, 10.1186/1479-5876-6-5
Curzons, 2001, So you think your process is green, how do you know? — Using principles of sustainability to determine what is green — a corporate perspective, Green Chem., 3, 1, 10.1039/b007871i
Czollner, 2000, Preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepine, 28
David, 2015, The pharmaceutical industry and natural products: historical status and new trends, Phytochem. Rev., 14, 299, 10.1007/s11101-014-9367-z
De Luca, 2012, Mining the biodiversity of plants: a revolution in the making, Science, 336, 1658, 10.1126/science.1217410
Debnath, 2006, Micropropagation: a tool for the production of high quality plant-based medicines, Curr. Pharm. Biotechnol., 7, 33, 10.2174/138920106775789638
Deng, 2014, Monoterpenoids from the whole herb of Veronicastrum axillare, Pharm. Biol., 52, 661, 10.3109/13880209.2013.863947
Denis, 1988, Highly efficient, practical approach to natural taxol, J. Am. Chem. Soc., 110, 5917, 10.1021/ja00225a063
Dicks, 2015
Doma, 2012, Carbohydrate and elicitor enhanced withanolide (withaferin A and withanolide A) accumulation in hairy root cultures of Withania somnifera (L.), Indian J. Exp. Biol., 50, 484
Dörnenburg, 1995, Strategies for the improvement of secondary metabolite production in plant cell cultures, Enzym. Microb. Technol., 17, 674, 10.1016/0141-0229(94)00108-4
Drahl, 2013, Chemists find more efficient total synthesis route to Ingenol, Chem. Eng. News, 91, 16-16
Dunn, 2005, Measuring the metabolome: current analytical technologies, Analyst, 130, 606, 10.1039/b418288j
Duwensee, 2011, Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein, Atherosclerosis, 219, 109, 10.1016/j.atherosclerosis.2011.07.023
Ebada, 2008, Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates, Nat. Protoc., 3, 1820, 10.1038/nprot.2008.182
Eckelbarger, 2008, Synthesis of antiproliferative Cephalotaxus esters and their evaluation against several human hematopoietic and solid tumor cell lines: uncovering differential susceptibilities to multidrug resistance, Chemistry, 14, 4293, 10.1002/chem.200701998
Eddershaw, 2000, ADME/PK as part of a rational approach to drug discovery, Drug Discov. Today, 5, 409, 10.1016/S1359-6446(00)01540-3
Egan, 2012, Coproduction and ecological significance of naphthoquinones in carnivorous sundews (Drosera), Chem. Biodivers., 9, 1033, 10.1002/cbdv.201100274
Eichhorn, 1998, Biosynthesis of the Amaryllidaceae alkaloid galanthamine, Phytochemistry, 49, 1037, 10.1016/S0031-9422(97)01024-8
Eisenberg, 2011, Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation — rationale, methods and preliminary results from a Sino-American collaboration, Fitoterapia, 82, 17, 10.1016/j.fitote.2010.11.017
Ekuadzi, 2014, Flavonoid glycosides from the stem bark of Margaritaria discoidea demonstrate antibacterial and free radical scavenging activities, Phytother. Res., 28, 784, 10.1002/ptr.5053
Eldridge, 2002, High-throughput method for the production and analysis of large natural product libraries for drug discovery, Anal. Chem., 74, 3963, 10.1021/ac025534s
EMA, 2006
Endoma, 2002, Medium-scale preparation of useful metabolites of aromatic compounds via whole-cell fermentation with recombinant organisms, Org. Process Res. Dev., 6, 525, 10.1021/op020013s
Engels, 2008, Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production, Metab. Eng., 10, 201, 10.1016/j.ymben.2008.03.001
EPA, 2002
Fabricant, 2001, The value of plants used in traditional medicine for drug discovery, Environ. Health Perspect., 109, 69, 10.1289/ehp.01109s169
Fakhrudin, 2010, Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma, Mol. Pharmacol., 77, 559, 10.1124/mol.109.062141
Fakhrudin, 2014, Identification of plumericin as a potent new inhibitor of the NF-kappaB pathway with anti-inflammatory activity in vitro and in vivo, Br. J. Pharmacol., 171, 1676, 10.1111/bph.12558
Fallarero, 2014, How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens, Planta Med., 80, 1182, 10.1055/s-0034-1383061
Farhi, 2011, Generation of the potent anti-malarial drug artemisinin in tobacco, Nat. Biotechnol., 29, 1072, 10.1038/nbt.2054
Farhi, 2013, Metabolic engineering of plants for artemisinin synthesis, Biotechnol. Genet. Eng. Rev., 29, 135, 10.1080/02648725.2013.821283
Farnsworth, 1985, Medicinal plants in therapy, Bull. World Health Organ., 63, 965
Feher, 2003, Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry, J. Chem. Inf. Comput. Sci., 43, 218, 10.1021/ci0200467
Felter, 1898
Fernandez-Castane, 2014, Computer-aided design for metabolic engineering, J. Biotechnol., 192, 302, 10.1016/j.jbiotec.2014.03.029
Fernando, 2013, Multiple metal accumulation within a manganese-specific genus, Am. J. Bot., 100, 690, 10.3732/ajb.1200545
Forbey, 2009, Exploitation of secondary metabolites by animals: a response to homeostatic challenges, Integr. Comp. Biol., 49, 314, 10.1093/icb/icp046
Foster, 2014, Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies, Xenobiotica, 44, 109, 10.3109/00498254.2013.867553
Franz, 1991, Kultivierung bedeutender wildwachsender Arznei- und Gewürzpflanzen, Entw ländl raum., 4, 3
Frense, 2007, Taxanes: perspectives for biotechnological production, Appl. Microbiol. Biotechnol., 73, 1233, 10.1007/s00253-006-0711-0
Fürst, 2014, Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress, Mediat. Inflamm., 2014:2014, 146832
Gaascht, 2014, Plumbagin modulates leukemia cell redox status, Molecules, 19, 10011, 10.3390/molecules190710011
Gairola, 2014, A cross-cultural analysis of Jammu, Kashmir and Ladakh (India) medicinal plant use, J. Ethnopharmacol., 155, 925, 10.1016/j.jep.2014.06.029
Gao, 2011, New triterpenoid saponins from Patrinia scabiosaefolia, Carbohydr. Res., 346, 2881, 10.1016/j.carres.2011.10.008
Gaulton, 2012, ChEMBL: a large-scale bioactivity database for drug discovery, Nucleic Acids Res., 40, D1100, 10.1093/nar/gkr777
Gavernet, 2008, A combined virtual screening 2D and 3D QSAR methodology for the selection of new anticonvulsant candidates from a natural product library, QSAR Comb. Sci., 27, 1120, 10.1002/qsar.200730055
Georgiev, 2007, Hairy root type plant in vitro systems as sources of bioactive substances, Appl. Microbiol. Biotechnol., 74, 1175, 10.1007/s00253-007-0856-5
Georgiev, 2012, Genetically transformed roots: from plant disease to biotechnological resource, Trends Biotechnol., 30, 528, 10.1016/j.tibtech.2012.07.001
Gertsch, 2011, Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures, Planta Med., 77, 1086, 10.1055/s-0030-1270904
Gezginci, 2001, A short synthetic route to nordihydroguaiaretic acid (NDGA) and its stereoisomer using Ti-induced carbonyl-coupling reaction, Tetrahedron Lett., 42, 6083, 10.1016/S0040-4039(01)01182-0
Ghavimi, 2014, Total synthesis of 8,14-dihydromorphinandienone alkaloids, Org. Lett., 16, 1708, 10.1021/ol500368p
Gibert, 2013, Zebrafish as a genetic model in pre-clinical drug testing and screening, Curr. Med. Chem., 20, 2458, 10.2174/0929867311320190005
Gleeson, 2011, Probing the links between in vitro potency, ADMET and physicochemical parameters, Nat. Rev. Drug Discov., 10, 197, 10.1038/nrd3367
Glenn, 2013, Recent progress in the metabolic engineering of alkaloids in plant systems, Curr. Opin. Biotechnol., 24, 354, 10.1016/j.copbio.2012.08.003
Gosset, 2009, Production of aromatic compounds in bacteria, Curr. Opin. Biotechnol., 20, 651, 10.1016/j.copbio.2009.09.012
Gras, 2013, Ingenol mebutate: a new option for actinic keratosis treatment, Drugs Today (Barc.), 49, 15, 10.1358/dot.2013.49.1.1910723
Graz, 2013, What is “clinical data”? Why and how can they be collected during field surveys on medicinal plants?, J. Ethnopharmacol., 150, 775, 10.1016/j.jep.2013.08.036
Grienke, 2011, Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum, Bioorg. Med. Chem., 19, 6779, 10.1016/j.bmc.2011.09.039
Grienke, 2014, Computer-guided approach to access the anti-influenza activity of licorice constituents, J. Nat. Prod., 77, 563, 10.1021/np400817j
Guasch, 2012, Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays, PLoS One, 7, e44971, 10.1371/journal.pone.0044971
Guenard, 1993, Taxol and taxotere: discovery, chemistry, and structure–activity relationships, Acc. Chem. Res., 26, 160, 10.1021/ar00028a005
Guerrero, 2013, Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells, J. Nutr. Biochem., 24, 2092, 10.1016/j.jnutbio.2013.08.001
Guillon, 2006, Harnessing the potential of hairy roots: dawn of a new era, Trends Biotechnol., 24, 403, 10.1016/j.tibtech.2006.07.002
Gul, 2010, Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery, Expert Opin. Drug Discovery, 5, 681, 10.1517/17460441.2010.495748
Gulcemal, 2013, Oleanane glycosides from Astragalus tauricolus: isolation and structural elucidation based on a preliminary liquid chromatography-electrospray ionization tandem mass spectrometry profiling, Phytochemistry, 86, 184, 10.1016/j.phytochem.2012.10.001
Gulcin, 2012, Antioxidant activity of food constituents: an overview, Arch. Toxicol., 86, 345, 10.1007/s00204-011-0774-2
Gunawardana, 1992, Isolation of 9-dihydro-13-acetylbaccatin III from Taxus canadensis, J. Nat. Prod., 55, 1686, 10.1021/np50089a022
Guo, 2008, In vitro metabolism of isoliquiritigenin by human liver microsomes, Drug Metab. Dispos., 36, 461, 10.1124/dmd.107.018721
Guo, 2013, Two novel furostanol saponins from the tubers of Ophiopogon japonicus, J. Asian Nat. Prod. Res., 15, 459, 10.1080/10286020.2013.783024
Guo, 2014, The therapeutic value of natural products derived from Chinese medicine — a systems based perspective, Eur. J. Intern. Med., 6, 617, 10.1016/j.eujim.2014.09.132
Gyllenhaal, 2012, Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesis, Pharm. Biol., 50, 30, 10.3109/13880209.2011.634424
Haberlandt, 1902, Culturversuche mit isolierten Pflanzenzellen, Sitzungsber. Akad. Wiss. Wien. Math. Nat., 111, 69
Han, 2014, Collective synthesis of humulanolides using a metathesis cascade reaction, J. Am. Chem. Soc., 136, 13610, 10.1021/ja5084927
Hanke, 2013, Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo, J. Med. Chem., 56, 9031, 10.1021/jm401557w
Harinantenaina, 2008, Chemical and biologically active constituents of Pteris multifida, J. Nat. Med., 62, 452, 10.1007/s11418-008-0265-9
Harrington, 2004, Research and development of a second-generation process for oseltamivir phosphate, prodrug for a neuraminidase inhibitor, Org. Process Res. Dev., 8, 86, 10.1021/op0302107
Harrison, 2014, Patenting natural products just got harder, Nat. Biotechnol., 32, 403, 10.1038/nbt0514-403a
Hartler, 2011, Lipid Data Analyzer: unattended identification and quantitation of lipids in LC–MS data, Bioinformatics, 27, 572, 10.1093/bioinformatics/btq699
Hassig, 2014, Ultra-high-throughput screening of natural product extracts to identify proapoptotic inhibitors of Bcl-2 family proteins, J. Biomol. Screen., 19, 1201, 10.1177/1087057114536227
Hayashi, 2009, Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators, PLoS One, 4, e7655, 10.1371/journal.pone.0007655
Hein, 2010, Docking compared to 3D-pharmacophores: the scoring function challenge, Drug Discov. Today Technol., 7, e229, 10.1016/j.ddtec.2010.12.003
Heinrich, 2010, Ethnopharmacology in the 21st century — grand challenges, Front. Pharmacol., 1, 8, 10.3389/fphar.2010.00008
Heinrich, 2010, 3.12 — Ethnopharmacology and drug discovery, 351
Heinrich, 2001, Ethnopharmacology in drug discovery: an analysis of its role and potential contribution, J. Pharm. Pharmacol., 53, 425, 10.1211/0022357011775712
Heinstein, 1981, Formation of gossypol by Gossypium hirsutum L. cell suspension cultures, J. Nat. Prod., 44, 1, 10.1021/np50013a001
Heiss, 2014, Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata, J. Nat. Prod., 77, 503, 10.1021/np400778m
Henrich, 2013, Matching the power of high throughput screening to the chemical diversity of natural products, Nat. Prod. Rep., 30, 1284, 10.1039/c3np70052f
Henrich, 2006, A high-throughput cell-based assay for inhibitors of ABCG2 activity, J. Biomol. Screen., 11, 176, 10.1177/1087057105284576
Hermann, 2013, Metal impurities cause false positives in high-throughput screening campaigns, ACS Med. Chem. Lett., 4, 197, 10.1021/ml3003296
Holton, 1990, Method for preparation of taxol, 18
Hong, 2014, Natural product synthesis at the interface of chemistry and biology, Chemistry, 20, 10204, 10.1002/chem.201402804
Hoon, 2008, Yeast chemical genomics and drug discovery: an update, Trends Pharmacol. Sci., 29, 499, 10.1016/j.tips.2008.07.006
Hostanska, 2014, Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix, J. Pharm. Pharmacol., 66, 1606, 10.1111/jphp.12242
Hosztafi, 1997, The discovery of alkaloids, Pharmazie, 52, 546
Hou, 2010, Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants, J. Nutr. Biochem., 21, 1045, 10.1016/j.jnutbio.2009.08.010
Howat, 2014, Paclitaxel: biosynthesis, production and future prospects, N. Biotechnol., 31, 242, 10.1016/j.nbt.2014.02.010
Hsu, 1974, Studies on the components of Formosan Solanum species, 26, 102338t
Huang, 2004, Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR, Mol. Endocrinol., 18, 2402, 10.1210/me.2004-0046
Huang, 2007, Anti-platelet aggregation triterpene saponins from the galls of Sapindus mukorossi, Chem. Pharm. Bull. (Tokyo), 55, 1412, 10.1248/cpb.55.1412
Huang, 2011, Heritable gene targeting in zebrafish using customized TALENs, Nat. Biotechnol., 29, 699, 10.1038/nbt.1939
Huang, 2014, Optimal inductive and cultural conditions of Polygonum multiflorum transgenic hairy roots mediated with Agrobacterium rhizogenes R1601 and an analysis of their anthraquinone constituents, Pharmacogn. Mag., 10, 77, 10.4103/0973-1296.126671
Hudlicky, 2006, Chemoenzymatic synthesis of complex natural andunnatural products: morphine, pancratistatin, and their analogs, ARKIVOC, 276–291
Hudlický, 2007
Hudlicky, 2009, Celebrating 20years of SYNLETT — special account on the merits of biocatalysis and the impact of arene cis-dihydrodiols on enantioselective synthesis, Synlett, 685, 10.1055/s-0028-1087946
Huffman, 2003, Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants, Proc. Nutr. Soc., 62, 371, 10.1079/PNS2003257
Hunter, 2008, Harnessing nature's wisdom. Turning to nature for inspiration and avoiding her follies, EMBO Rep., 9, 838, 10.1038/embor.2008.160
Imming, 2006, Drugs, their targets and the nature and number of drug targets, Nat. Rev. Drug Discov., 5, 821, 10.1038/nrd2132
Inui, 2012, Unbiased evaluation of bioactive secondary metabolites in complex matrices, Fitoterapia, 83, 1218, 10.1016/j.fitote.2012.06.012
IUCN, 2015
Jackson, 1984, Biosynthesis of Podophyllum lignans — II. Interconversions of aryltetralin lignans in Podophyllum hexandrum, Phytochemistry, 23, 1037, 10.1016/S0031-9422(00)82604-7
Janaki, 1967, An improved method for the isolation of curcumin from turmeric, Curcuma longa L, J. Indian Chem. Soc., 44, 985
Jang, 2012, In vivo anti-oxidant and anti-inflammatory activities of cambial meristematic cells established from Ginkgo biloba L, J. Med. Plant Res., 6, 3048
Jankevics, 2012, Separating the wheat from the chaff: a prioritisation pipeline for the analysis of metabolomics datasets, Metabolomics, 8, 29, 10.1007/s11306-011-0341-0
Jensen, 2014, Recent applications of synthetic biology tools for yeast metabolic engineering, FEMS Yeast Res., 10.1111/1567-1364.12185
Johnson, 2011, Natural product libraries to accelerate the high-throughput discovery of therapeutic leads, J. Nat. Prod., 74, 2545, 10.1021/np200673b
Jones, 2012, Extraction of plant secondary metabolites, Methods Mol. Biol., 864, 341, 10.1007/978-1-61779-624-1_13
Jones, 2011, Drugs from daffodils, Chem. Ind., 18
Jones, 2011, Collective synthesis of natural products by means of organocascade catalysis, Nature, 475, 183, 10.1038/nature10232
Jørgensen, 2013, 14-Step synthesis of (+)-ingenol from (+)-3-carene, Science, 341, 878, 10.1126/science.1241606
Joshi, 1979, Quinones and other constituents from Haplophragma adenophyllum, Planta Med., 37, 60, 10.1055/s-0028-1097296
Junio, 2011, Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis), J. Nat. Prod., 74, 1621, 10.1021/np200336g
Kada, 1985, Detection and chemical identification of natural bio-antimutagens: a case of the green tea factor, Mutat. Res., 150, 127, 10.1016/0027-5107(85)90109-5
Kaga, 1989, A facile procedure for synthesis of capsaicin, J. Org. Chem., 54, 3477, 10.1021/jo00275a040
Kaiser, 2008, Von der Pflanze zur Chemie — Die Frühgeschichte der “Rheumamittel”, Z. Rheumatol., 67, 252, 10.1007/s00393-008-0257-x
Kalidindi, 2007, Enantioselective synthesis of arglabin, Angew. Chem. Int. Ed. Engl., 46, 6361, 10.1002/anie.200701584
Kamleh, 2008, Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules, Rapid Commun. Mass Spectrom., 22, 1912, 10.1002/rcm.3564
Kanokwaree, 1997, Effect of inoculum size on growth of Atropa belladonna hairy roots in shake flasks, J. Ferment. Bioeng., 84, 378, 10.1016/S0922-338X(97)89266-5
Kaserer, 2014, Polypharmacology and adverse bioactivty profiles predict potential toxicity and drug-related ADRs, 23
Kawaguchi, 2010, Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or isoflurane, PLoS One, 5, e11172, 10.1371/journal.pone.0011172
Keerthi, 2014, Metabolic profiling of Zingiber zerumbet following Pythium myriotylum infection: investigations on the defensive role of the principal secondary metabolite, zerumbone, Appl. Biochem. Biotechnol., 172, 2593, 10.1007/s12010-013-0707-z
Kervinen, 2010, Potency variation of small-molecule chymase inhibitors across species, Biochem. Pharmacol., 80, 1033, 10.1016/j.bcp.2010.06.014
Khafagi, 2000, The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds, J. Ethnopharmacol., 71, 365, 10.1016/S0378-8741(00)00164-1
Kim, 2011, A flow-microreactor approach to protecting-group-free synthesis using organolithium compounds, Nat. Commun., 2, 10.1038/ncomms1264
Kinghorn, 2011, The relevance of higher plants in lead compound discovery programs, J. Nat. Prod., 74, 1539, 10.1021/np200391c
Kingston, 2011, Modern natural products drug discovery and its relevance to biodiversity conservation, J. Nat. Prod., 74, 496, 10.1021/np100550t
Kirakosyan, 2009, The use of plant cell biotechnology for the production of phytochemicals, 15
Kirby, 2010, Cloning of casbene and neocembrene synthases from Euphorbiaceae plants and expression in Saccharomyces cerevisiae, Phytochemistry, 71, 1466, 10.1016/j.phytochem.2010.06.001
Kjer, 2010, Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products, Nat. Protoc., 5, 479, 10.1038/nprot.2009.233
Klayman, 1985, Qinghaosu (artemisinin): an antimalarial drug from China, Science, 228, 1049, 10.1126/science.3887571
Klayman, 1984, Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States, J. Nat. Prod., 47, 715, 10.1021/np50034a027
Klebe, 2009
Koehn, 2005, The evolving role of natural products in drug discovery, Nat. Rev. Drug Discov., 4, 206, 10.1038/nrd1657
Kola, 2004, Can the pharmaceutical industry reduce attrition rates?, Nat. Rev. Drug Discov., 3, 711, 10.1038/nrd1470
Kolewe, 2008, Pharmaceutically active natural product synthesis and supply via plant cell culture technology, Mol. Pharm., 5, 243, 10.1021/mp7001494
Kong, 2009, Where is the hope for drug discovery? Let history tell the future, Drug Discov. Today, 14, 115, 10.1016/j.drudis.2008.07.002
Kong, 2013, Artemisinic acid: a promising molecule potentially suitable for the semi-synthesis of artemisinin, RSC Adv., 3, 7622, 10.1039/c3ra40525g
Kovacs, 2007, Redirection of carotenoid metabolism for the efficient production of taxadiene [taxa-4(5),11(12)-diene] in transgenic tomato fruit, Transgenic Res., 16, 121, 10.1007/s11248-006-9039-x
Krief, 2004, Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda, Antimicrob. Agents Chemother., 48, 3196, 10.1128/AAC.48.8.3196-3199.2004
Krief, 2006, Bioactive properties of plant species ingested by chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park, Uganda, Am. J. Primatol., 68, 51, 10.1002/ajp.20206
Kruse, 2007, Geschichte der Pharmazie. Vol. II: Von der Frühen Neuzeit bis zur Gegenwart — by Rudolf Schmitz, Centaurus, 49, 182, 10.1111/j.1600-0498.2007.00061_4.x
Küenburg, 1999, Development of a pilot scale process for the anti-Alzheimer drug (−)-galanthamine using large-scale phenolic oxidative coupling and crystallisation-induced chiral conversion, Org. Process Res. Dev., 3, 425, 10.1021/op990019q
Kunwar, 2009, Indigenous use and ethnopharmacology of medicinal plants in far-west Nepal, Ethnobot. Res. Appl., 7, 5, 10.17348/era.7.0.5-28
Kurin, 2012, Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation, Planta Med., 78, 772, 10.1055/s-0031-1298440
Kuttruff, 2014, Natural product synthesis in the age of scalability, Nat. Prod. Rep., 31, 419, 10.1039/C3NP70090A
Kuzuyama, 2003, Diversity of the biosynthesis of the isoprene units, Nat. Prod. Rep., 20, 171, 10.1039/b109860h
Ladurner, 2012, Ascorbate stimulates endothelial nitric oxide synthase enzyme activity by rapid modulation of its phosphorylation status, Free Radic. Biol. Med., 52, 2082, 10.1016/j.freeradbiomed.2012.03.022
Laird, 2010, How to minimise scale up difficulties, Chem. Ind. Dig., 23, 51
Langcake, 1976, The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury, Physiol. Plant Pathol., 9, 77, 10.1016/0048-4059(76)90077-1
Lange, 2013, Metabolic engineering of plant monoterpenes, sesquiterpenes and diterpenes — current status and future opportunities, Plant Biotechnol. J., 11, 169, 10.1111/pbi.12022
Larsen, 2010, Using a phylogenetic approach to selection of target plants in drug discovery of acetylcholinesterase inhibiting alkaloids in Amaryllidaceae tribe Galantheae, Biochem. Syst. Ecol., 38, 1026, 10.1016/j.bse.2010.10.005
Larsen, 2014, The role of HTS in drug discovery at the University of Michigan, Comb. Chem. High Throughput Screen., 17, 210, 10.2174/1386207317666140109121546
Larsson, 2007, ChemGPS-NP: tuned for navigation in biologically relevant chemical space, J. Nat. Prod., 70, 789, 10.1021/np070002y
Lee, 2013, Target deconvolution techniques in modern phenotypic profiling, Curr. Opin. Chem. Biol., 17, 118, 10.1016/j.cbpa.2012.12.022
Lee, 2001, Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries, J. Comb. Chem., 3, 284, 10.1021/cc000097l
Lee, 1998, Total synthesis of colchicine. α-Methoxy-substituted oxyallyl [4+3] cycloaddition approach, J. Org. Chem., 63, 2804, 10.1021/jo980220j
Lee, 2010, Cultured cambial meristematic cells as a source of plant natural products, Nat. Biotechnol., 28, 1213, 10.1038/nbt.1693
Lee, 2012, Modern phenotypic drug discovery is a viable, neoclassic pharma strategy, J. Med. Chem., 55, 4527, 10.1021/jm201649s
Leete, 1960, The biogenesis of the alkaloids of Colchicum. I. The incorporation of phenylalanine into colchicine1, J. Am. Chem. Soc., 82, 6055, 10.1021/ja01508a021
Leonti, 2011, The future is written: impact of scripts on the cognition, selection, knowledge and transmission of medicinal plant use and its implications for ethnobotany and ethnopharmacology, J. Ethnopharmacol., 134, 542, 10.1016/j.jep.2011.01.017
Levesque, 2012, Continuous-flow synthesis of the anti-malaria drug artemisinin, Angew. Chem. Int. Ed. Engl., 51, 1706, 10.1002/anie.201107446
Lewis, 2003, Medical botany
Li, 2014, Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology, Curr. Opin. Plant Biol., 19, 8, 10.1016/j.pbi.2014.02.005
Li, 2009, Drug discovery and natural products: end of an era or an endless frontier?, Science, 325, 161, 10.1126/science.1168243
Li, 2010, PubChem as a public resource for drug discovery, Drug Discov. Today, 15, 1052, 10.1016/j.drudis.2010.10.003
Li, 2013, Collective synthesis of lycopodium alkaloids and tautomer locking strategy for the total synthesis of (−)-lycojapodine A, J. Org. Chem., 78, 800, 10.1021/jo3017555
Liang, 2012, Semisynthesis of ingenol 3-angelate (PEP005): efficient stereoconservative angeloylation of alcohols, Synlett, 23, 2647, 10.1055/s-0032-1317415
Liljegren, 1971, Glucosylation of solasodine by extracts from Solanum laciniatum, Phytochemistry, 10, 3061, 10.1016/S0031-9422(00)97352-7
Ling, 2012, Systematic screening and characterization of the major bioactive components of Poria cocos and their metabolites in rats by LC–ESI–MS(n), Biomed. Chromatogr., 26, 1109, 10.1002/bmc.1756
Lipinski, 2004, Navigating chemical space for biology and medicine, Nature, 432, 855, 10.1038/nature03193
Liu, 2008, Preparation of botanical samples for biomedical research, Endocr. Metab. Immune Disord. Drug Targets, 8, 112, 10.2174/187153008784534358
Liu, 2008, Botanical drugs: challenges and opportunities: contribution to Linnaeus Memorial Symposium 2007, Life Sci., 82, 445, 10.1016/j.lfs.2007.11.007
Liu, 2013, Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2, BMC Pharmacol. Toxicol., 14, 36, 10.1186/2050-6511-14-36
Lo, 2013, Microbial engineering strategies to improve cell viability for biochemical production, Biotechnol. Adv., 31, 903, 10.1016/j.biotechadv.2013.02.001
Lubbe, 2011, Cultivation of medicinal and aromatic plants for specialty industrial materials, Ind. Crop. Prod., 34, 785, 10.1016/j.indcrop.2011.01.019
Luo, 1998, Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata), Eur. J. Pharmacol., 346, 77, 10.1016/S0014-2999(98)00139-3
Luo, 2013, Ex vivo and in situ approaches used to study intestinal absorption, J. Pharmacol. Toxicol. Methods, 68, 208, 10.1016/j.vascn.2013.06.001
Mabona, 2013, Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound, J. Ethnopharmacol., 148, 45, 10.1016/j.jep.2013.03.056
Maclean, 2011, Recent ecological responses to climate change support predictions of high extinction risk, Proc. Natl. Acad. Sci. U. S. A., 108, 12337, 10.1073/pnas.1017352108
Maes, 2012, Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae, PLoS One, 7, e43850, 10.1371/journal.pone.0043850
Makky, 2008, A whole-animal microplate assay for metabolic rate using zebrafish, J. Biomol. Screen., 13, 960, 10.1177/1087057108326080
Malik, 2011, Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review, Process Biochem., 46, 23, 10.1016/j.procbio.2010.09.004
Mans, 2000, Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds, Oncologist, 5, 185, 10.1634/theoncologist.5-3-185
Mao, 2012, Target separation of a new anti-tumor saponin and metabolic profiling of leaves of Panax notoginseng by liquid chromatography with eletrospray ionization quadrupole time-of-flight mass spectrometry, J. Pharm. Biomed. Anal., 59, 67, 10.1016/j.jpba.2011.10.004
Maree, 2014, The application of GC–MS combined with chemometrics for the identification of antimicrobial compounds from selected commercial essential oils, Chemom. Intell. Lab., 130, 172, 10.1016/j.chemolab.2013.11.004
Marienhagen, 2013, Metabolic engineering of microorganisms for the synthesis of plant natural products, J. Biotechnol., 163, 166, 10.1016/j.jbiotec.2012.06.001
Mashkovsky, 1951, On the pharmacology of the new alkaloid galantamine, Farmacol. Toxicol. (Mosk.), 14, 27
McKerrall, 2014, Development of a concise synthesis of (+)-ingenol, J. Am. Chem. Soc., 136, 5799, 10.1021/ja501881p
Mehrotra, 2007, Efficiency of liquid culture systems over conventional micropropagation: A progress towards commercialization, Afr. J. Biotechnol., 6, 1484
Miettinen, 2014, The seco-iridoid pathway from Catharanthus roseus, Nat. Commun., 5, 3606, 10.1038/ncomms4606
Miller, 2011, A TALE nuclease architecture for efficient genome editing, Nat. Biotechnol., 29, 143, 10.1038/nbt.1755
Minic, 2005, Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors, Curr. Med. Chem., 12, 961, 10.2174/0929867053507261
Miralpeix, 2013, Metabolic engineering of plant secondary products: which way forward?, Curr. Pharm. Des., 19, 5622, 10.2174/1381612811319310016
Modarai, 2010, Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4), Planta Med., 76, 378, 10.1055/s-0029-1186152
Moerman, 1998, Native North American food and medicinal plants: epistemological considerations, 69
Moon, 2009, Antioxidant assays for plant and food components, J. Agric. Food Chem., 57, 1655, 10.1021/jf803537k
Mora-Pale, 2013, Metabolic engineering and in vitro biosynthesis of phytochemicals and non-natural analogues, Plant Sci., 210, 10, 10.1016/j.plantsci.2013.05.005
Mora-Pale, 2014, Biochemical strategies for enhancing the in vitro production of natural products with pharmaceutical potential, Curr. Opin. Biotechnol., 25, 86, 10.1016/j.copbio.2013.09.009
Murthy, 2014, Production of secondary metabolites from cell and organ cultures: Strategies and approaches for biomass improvement and metabolite accumulation, Plant Cell Tissue Organ Cult., 118, 1, 10.1007/s11240-014-0467-7
Nacoulma, 2013, Metabolomic-based study of the leafy gall, the ecological niche of the phytopathogen rhodococcus fascians, as a potential source of bioactive compounds, Int. J. Mol. Sci., 14, 12533, 10.3390/ijms140612533
Namdeo, 2007, Plant cell elicitation for production of secondary metabolites: a review, Phcog. Rev., 1, 69
Ndhlala, 2013, Anti-oxidative and cholinesterase inhibitory effects of leaf extracts and their isolated compounds from two closely related Croton species, Molecules, 18, 1916, 10.3390/molecules18021916
Newman, 2012, Natural products as sources of new drugs over the 30years from 1981 to 2010, J. Nat. Prod., 75, 311, 10.1021/np200906s
Ngo, 2013, 21st century natural product research and drug development and traditional medicines, Nat. Prod. Rep., 30, 584, 10.1039/c3np20120a
Nicolaou, 2014, Organic synthesis: the art and science of replicating the molecules of living nature and creating others like them in the laboratory, Proc. R. Soc. A, 470, 10.1098/rspa.2013.0690
Nicolaou, 1998, The art and science of organic and natural products synthesis, J. Chem. Educ., 75, 1226, 10.1021/ed075p1225
Nielsen, 2012, Identification of catechols as histone–lysine demethylase inhibitors, FEBS Lett., 586, 1190, 10.1016/j.febslet.2012.03.001
Nievergelt, 2010, Identification of serotonin 5-HT1A receptor partial agonists in ginger, Bioorg. Med. Chem., 18, 3345, 10.1016/j.bmc.2010.02.062
Ningthoujam, 2012, Challenges in developing medicinal plant databases for sharing ethnopharmacological knowledge, J. Ethnopharmacol., 141, 9, 10.1016/j.jep.2012.02.042
Nitteranon, 2011, Isolation and synergism of in vitro anti-inflammatory and quinone reductase (QR) inducing agents from the fruits of Morinda citrifolia (noni), Food Res. Int., 44, 2271, 10.1016/j.foodres.2010.11.009
Noreen, 1998, Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis, J. Nat. Prod., 61, 8, 10.1021/np970198+
Obbo, 2013, Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication, J. Ethnopharmacol., 147, 220, 10.1016/j.jep.2013.03.007
Obembe, 2011, Advances in plant molecular farming, Biotechnol. Adv., 29, 210, 10.1016/j.biotechadv.2010.11.004
Oliva, 2011, Sharing the benefits of biodiversity: a new international protocol and its implications for research and development, Planta Med., 77, 1221, 10.1055/s-0031-1279978
Oliveira, 2011, Ethnopharmacological versus random plant selection methods for the evaluation of the antimycobacterial activity, Rev. Bras. Farmacogn., 21, 793, 10.1590/S0102-695X2011005000084
Ongley, 2013, Recent advances in the heterologous expression of microbial natural product biosynthetic pathways, Nat. Prod. Rep., 30, 1121, 10.1039/c3np70034h
Ono, 2011, The multiplicity of hairy root cultures: prolific possibilities, Plant Sci., 180, 439, 10.1016/j.plantsci.2010.11.012
Oprea, 2001, Chemography: the art of navigating in chemical space, J. Comb. Chem., 3, 157, 10.1021/cc0000388
O'Reilly, 2014, C. elegans in high-throughput drug discovery, Adv. Drug Deliv. Rev., 69–70, 247, 10.1016/j.addr.2013.12.001
Orlikova, 2013, Styryl-lactone goniothalamin inhibits TNF-alpha-induced NF-kappaB activation, Food Chem. Toxicol., 59, 572, 10.1016/j.fct.2013.06.051
Ortholand, 2004, Natural products and combinatorial chemistry: back to the future, Curr. Opin. Chem. Biol., 8, 271, 10.1016/j.cbpa.2004.04.011
Paddon, 2014, Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development, Nat. Rev. Microbiol., 12, 355, 10.1038/nrmicro3240
Paddon, 2013, High-level semi-synthetic production of the potent antimalarial artemisinin, Nature, 496, 528, 10.1038/nature12051
Pandey, 2014, Establishment of hairy root culture and production of secondary metabolites in Coleus (Coleus forskohlii), J. Med. Plant Res., 8, 58, 10.5897/JMPR12.1182
Pantev, 2006, Biologically active constituents of a polyphenol extract from Geranium sanguineum L. with anti-influenza activity, Z. Naturforsch. C, 61, 508, 10.1515/znc-2006-7-807
Parasuraman, 2011, Toxicological screening, J. Pharmacol. Pharmacother., 2, 74, 10.4103/0976-500X.81895
Park, 2007, The protective effect of chlorophyll a against oxidative stress and inflammatory processes in LPS-stimulated macrophages, Food Sci. Biotechnol., 16, 205
Pastre, 2013, Flow chemistry syntheses of natural products, Chem. Soc. Rev., 42, 8849, 10.1039/c3cs60246j
Patel, 1994, Enzymic preparation of (3R-cis)-3-(acetyloxy)-4-phenyl-2-azetidinone: a taxol side-chain synthon, Biotechnol. Appl. Biochem., 20, 23
Paterson, 2005, Chemistry. The renaissance of natural products as drug candidates, Science, 310, 451, 10.1126/science.1116364
Pathmasiri, 2005, Aryl ketones from Acronychia pedunculata with cyclooxygenase-2 inhibitory effects, Chem. Biodivers., 2, 463, 10.1002/cbdv.200590026
Patwardhan, 2005, Ethnopharmacology and drug discovery, J. Ethnopharmacol., 100, 50, 10.1016/j.jep.2005.06.006
Patwardhan, 2010, Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches, Indian J. Exp. Biol., 48, 220
Pellegatti, 2013, Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing, Expert Opin. Drug Metab. Toxicol., 9, 1171, 10.1517/17425255.2013.804061
Pence, 2011, Evaluating costs for the in vitro propagation and preservation of endangered plants, In Vitro Cell Dev. Biol. Plant, 47, 176, 10.1007/s11627-010-9323-6
Perkin, 1899, LXXIX. — the colouring matters contained in dyer's broom (Genista tinctoria) and heather (Calluna vulgaris), J. Chem. Soc. Trans., 75, 830, 10.1039/CT8997500830
Peters, 2004, Metabolic engineering of plant secondary metabolism, 1, 609
Petrzilka, 1969, Synthesis of hashish components. IV, Helv. Chim. Acta, 52, 1102, 10.1002/hlca.19690520427
Pfisterer, 2011, In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3, Bioorg. Med. Chem., 19, 1002, 10.1016/j.bmc.2010.10.046
Picker, 2014, Plant extracts in cell-based anti-inflammatory assays — pitfalls and considerations related to removal of activity masking bulk components, Phytochem. Lett., 10, xli, 10.1016/j.phytol.2014.04.001
Pluskal, 2010, MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data, BMC Bioinf., 11, 395, 10.1186/1471-2105-11-395
Potterat, 2006, Natural products in drug discovery — concepts and approaches for tracking bioactivity, Curr. Org. Chem., 10, 899, 10.2174/138527206776894401
Powell, 1974, Isolation of antitumor alkaloids from Cephalotaxus harringtonia, Ind. Eng. Chem. Prod. Res. Dev., 13, 129, 10.1021/i360050a010
Prasain, 2001, Taxines from the needles of Taxus wallichiana, Phytochemistry, 58, 1167, 10.1016/S0031-9422(01)00305-3
Pulak, 2006, Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system, Methods Mol. Biol., 351, 275
Qiao, 2012, Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry, J. Chromatogr. A, 1258, 84, 10.1016/j.chroma.2012.08.041
Ramakrishna, 2011, Influence of abiotic stress signals on secondary metabolites in plants, Plant Signal. Behav., 6, 1720, 10.4161/psb.6.11.17613
Ramasamy, 2014, Vitiquinolone — a quinolone alkaloid from Hibiscus vitifolius Linn, Food Chem., 145, 970, 10.1016/j.foodchem.2013.08.128
Rao, 2002, Plant cell cultures: chemical factories of secondary metabolites, Biotechnol. Adv., 20, 101, 10.1016/S0734-9750(02)00007-1
Rask-Andersen, 2011, Trends in the exploitation of novel drug targets, Nat. Rev. Drug Discov., 10, 579, 10.1038/nrd3478
Ratner, 2010, Pfizer stakes a claim in plant cell-made biopharmaceuticals, Nat. Biotechnol., 28, 107, 10.1038/nbt0210-107
Read, 2007, Micropropagation: past, present and future, Acta Hortic., 17, 10.17660/ActaHortic.2007.748.1
Reed, 2015, The quest for a practical synthesis of morphine alkaloids and their derivatives by chemoenzymatic methods, Acc. Chem. Res., 48, 674, 10.1021/ar500427k
Reuter, 2009, Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells, Ann. N. Y. Acad. Sci., 1171, 436, 10.1111/j.1749-6632.2009.04731.x
Riva, 2011, Synthesis of (+)-dumetorine and congeners by using flow chemistry technologies, Chemistry, 17, 6221, 10.1002/chem.201100300
Roberts, 2010, Plant natural products from cultured multipotent cells, Nat. Biotechnol., 28, 1175, 10.1038/nbt1110-1175
Robertson, 2014, A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism, Sci. Transl. Med., 6, 225ra29, 10.1126/scitranslmed.3007672
Rollinger, 2004, Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example, J. Chem. Inf. Comput. Sci., 44, 480, 10.1021/ci030031o
Rollinger, 2008, Virtual screening for the discovery of bioactive natural products, Prog. Drug Res., 65, 213
Rollinger, 2009, In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens, Planta Med., 75, 195, 10.1055/s-0028-1088397
Ron, 2014, Hairy root transformation using Agrobacterium rhizogenes as a tool for exploring cell type-specific gene expression and function using tomato as a model, Plant Physiol., 166, 455, 10.1104/pp.114.239392
Rønsted, 2008, Phylogenetic selection of Narcissus species for drug discovery, Biochem. Syst. Ecol., 36, 417, 10.1016/j.bse.2007.12.010
Rosen, 2009, ChemGPS-NP(Web): chemical space navigation online, J. Comput. Aided Mol. Des., 23, 253, 10.1007/s10822-008-9255-y
Rout, 2000, In vitro manipulation and propagation of medicinal plants, Biotechnol. Adv., 18, 91, 10.1016/S0734-9750(99)00026-9
Sahu, 2013, A review on low cost methods for in vitro micropropagation of plant through tissue culture technique, UK J. Pharm. Biosci., 1, 38, 10.20510/ukjpb/1/i1/91115
Sandasi, 2012, An untargeted metabolomic approach in the chemotaxonomic assessment of two Salvia species as a potential source of alpha-bisabolol, Phytochemistry, 84, 94, 10.1016/j.phytochem.2012.08.009
Sarasan, 2011, Applications of phytochemical and in vitro techniques for reducing over-harvesting of medicinal and pesticidal plants and generating income for the rural poor, Plant Cell Rep., 30, 1163, 10.1007/s00299-011-1047-5
Sasiela, 2008, Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen, J. Biomol. Screen., 13, 229, 10.1177/1087057108315038
Saslis-Lagoudakis, 2011, The use of phylogeny to interpret cross-cultural patterns in plant use and guide medicinal plant discovery: an example from Pterocarpus (Leguminosae), PLoS One, 6, e22275, 10.1371/journal.pone.0022275
Saslis-Lagoudakis, 2012, Phylogenies reveal predictive power of traditional medicine in bioprospecting, Proc. Natl. Acad. Sci. U. S. A., 109, 15835, 10.1073/pnas.1202242109
Sathishkumar, 2013, Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng, Comput. Biol. Med., 43, 786, 10.1016/j.compbiomed.2013.02.020
Sauerwein, 1992, Further approaches in the production of secondary metabolites by plant tissue cultures, Plant Tissue Cult. Lett., 9, 1, 10.5511/plantbiotechnology1984.9.1
Scannell, 2012, Diagnosing the decline in pharmaceutical R&D efficiency, Nat. Rev. Drug Discov., 11, 191, 10.1038/nrd3681
Scheer, 2013, Xenobiotic receptor humanized mice and their utility, Drug Metab. Rev., 45, 110, 10.3109/03602532.2012.738687
Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat. Chem. Biol., 9, 232, 10.1038/nchembio.1199
Schiff, 1980, Taxol stabilizes microtubules in mouse fibroblast cells, Proc. Natl. Acad. Sci. U. S. A., 77, 1561, 10.1073/pnas.77.3.1561
Schiff, 1979, Promotion of microtubule assembly in vitro by taxol, Nature, 277, 665, 10.1038/277665a0
Schippmann, 2006, A comparison of cultivation and wild collection of medicinal and aromatic plants under sustainability aspects, 75
Schmid, 1999, Natural products in high throughput screening: automated high-quality sample preparation, J. Biomol. Screen., 4, 15, 10.1177/108705719900400104
Schmidt, 2008, A natural history of botanical therapeutics, Metabolism, 57, S3, 10.1016/j.metabol.2008.03.001
Schreiner, 2011, Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner, Cardiovasc. Res., 90, 140, 10.1093/cvr/cvq355
Schuster, 2010, 3D pharmacophores as tools for activity profiling, Drug Discov. Today Technol., 7, e205, 10.1016/j.ddtec.2010.11.006
Schuster, 2005, Why drugs fail — a study on side effects in new chemical entities, Curr. Pharm. Des., 11, 3545, 10.2174/138161205774414510
Schwaiberger, 2010, Indirubin-3′-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo, Arterioscler. Thromb. Vasc. Biol., 30, 2475, 10.1161/ATVBAHA.110.212654
Sertürner, 1817, Über das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandteile des Opiums, Ann. Phys., 25, 56, 10.1002/andp.18170550104
Shaneyfelt, 2006, Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay, Virol. J., 3, 68, 10.1186/1743-422X-3-68
Sharma, 2011, Enhancement of secondary metabolites in cultured plant cells through stress stimulus, Am. J. Plant Physiol., 6, 50, 10.3923/ajpp.2011.50.71
Sheldon, 1992, Organic synthesis — past, present and future, Chem. Ind., 903
Shilpa, 2010, An alternate method of natural drug production: eliciting secondary metabolite production using plant cell culture, J. Plant Sci., 5, 222, 10.3923/jps.2010.222.247
Siahsar, 2011, Application of biotechnology in production of medicinal plants, Am. Eur. J. Agric. Environ. Sci., 11, 439
Siddiqui, 2012, Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools, FEMS Yeast Res., 12, 144, 10.1111/j.1567-1364.2011.00774.x
Siriwatanametanon, 2011, The Thai medicinal plant Gynura pseudochina var. hispida: chemical composition and in vitro NF-kappaB inhibitory activity, Nat. Prod. Commun., 6, 627
Smith, 2006, XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification, Anal. Chem., 78, 779, 10.1021/ac051437y
Sneader, 2005
Soejarto, 2004, The UIC ICBG (University of Illinois at Chicago International Cooperative Biodiversity Group) Memorandum of Agreement: a model of benefit-sharing arrangement in natural products drug discovery and development, J. Nat. Prod., 67, 294, 10.1021/np0304363
Song, 2014, Microbial biosynthesis of medicinally important plant secondary metabolites, Nat. Prod. Rep., 31, 1497, 10.1039/C4NP00057A
Spjut, 1985, Limitations of a random screen: search for new anticancer drugs in higher plants, Econ. Bot., 39, 266, 10.1007/BF02858796
Stahura, 2000, Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations, J. Chem. Inf. Comput. Sci., 40, 1245, 10.1021/ci0003303
Staniek, 2014, Natural products — learning chemistry from plants, Biotechnol. J., 9, 326, 10.1002/biot.201300059
Steindl, 2006, Parallel screening: a novel concept in pharmacophore modeling and virtual screening, J. Chem. Inf. Model., 46, 2146, 10.1021/ci6002043
Steindl, 2007, Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models, J. Chem. Inf. Model., 47, 563, 10.1021/ci600321m
Stitt, 2011, Scale-up of chemical reactions, 155
Su, 2005, A nobel cyanogenic glycoside from Semiaquilegia adoxoides, J. Asian Nat. Prod. Res., 7, 171, 10.1080/10286020310001625148
Swindle, 2012, Swine as models in biomedical research and toxicology testing, Vet. Pathol., 49, 344, 10.1177/0300985811402846
Tafesh, 2011, Synergistic antibacterial effects of polyphenolic compounds from olive mill wastewater, Evid. Based Complement. Alternat. Med., 2011, 431021, 10.1155/2011/431021
Takenaka, 2001, Classical vs reverse pharmacology in drug discovery, BJU Int., 88, 7, 10.1111/j.1464-410X.2001.00112.x
Tan, 1991, Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, J. Nat. Prod., 54, 143, 10.1021/np50073a012
Tasheva, 2013, Role of biotechnology for protection of endangered medicinal plants
Tawfike, 2013, Metabolomics and dereplication strategies in natural products, Methods Mol. Biol., 1055, 227, 10.1007/978-1-62703-577-4_17
Teicher, 2009, In vivo/ex vivo and in situ assays used in cancer research: a brief review, Toxicol. Pathol., 37, 114, 10.1177/0192623308329473
Temml, 2013, Interaction of Carthamus tinctorius lignan arctigenin with the binding site of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase, FEBS Open Bio, 3, 450, 10.1016/j.fob.2013.08.008
Thoppil, 2013, Antitumor activities of extracts from selected desert plants against HepG2 human hepatocellular carcinoma cells, Pharm. Biol., 51, 668, 10.3109/13880209.2012.749922
Toh, 1955, The pharmacological actions of capsaicin and analogues, Br. J. Pharmacol. Chemother., 10, 175, 10.1111/j.1476-5381.1955.tb00079.x
Tomas-Barberan, 2014, Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status, J. Agric. Food Chem., 62, 6535, 10.1021/jf5024615
Tripathi, 2003, Role of biotechnology in medicinal plants, Trop. J. Pharm. Res., 2, 243
Trost, 1991, The atom economy: a search for synthetic efficiency, Science, 254, 1471, 10.1126/science.1962206
Trost, 2007, Synthesis of (−)-Δ9-trans-tetrahydrocannabinol: stereocontrol via Mo-catalyzed asymmetric allylic alkylation reaction, Org. Lett., 9, 861, 10.1021/ol063022k
Tu, 2010, Automated high-throughput system to fractionate plant natural products for drug discovery, J. Nat. Prod., 73, 751, 10.1021/np9007359
Unschuld, 1986
Uzuner, 2012, Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities, J. Ethnopharmacol., 140, 458, 10.1016/j.jep.2012.02.028
Vaidya, 2006, Reverse pharmacological correlates of ayurvedic drug actions, Indian J. Pharm., 38, 311, 10.4103/0253-7613.27697
van der Laan, 2010, Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products, J. Pharmacol. Toxicol. Methods, 62, 184, 10.1016/j.vascn.2010.05.005
Vasilev, 2014, Comparison of plant-based expression platforms for the heterologous production of geraniol, Plant Cell Tissue Organ Cult., 117, 373
Verpoorte, 1998, Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development, Drug Discov. Today, 3, 232, 10.1016/S1359-6446(97)01167-7
Verpoorte, 2000, Pharmacognosy in the new millennium: leadfinding and biotechnology, J. Pharm. Pharmacol., 52, 253, 10.1211/0022357001773931
Vines, 2004, Herbal harvests with a future
Vogel, 2002
Vogl, 2013, The herbal drug Melampyrum pratense L. (Koch): isolation and identification of its bioactive compounds targeting mediators of inflammation, Evid. Based Complement. Alternat. Med., 2013, 395316, 10.1155/2013/395316
Vree, 1972, Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side chain, J. Pharm. Pharmacol., 24, 7, 10.1111/j.2042-7158.1972.tb08857.x
Wagner, 2009, Synergy research: approaching a new generation of phytopharmaceuticals, Phytomedicine, 16, 97, 10.1016/j.phymed.2008.12.018
Waltenberger, 2011, Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine, Phytomedicine, 18, 119, 10.1016/j.phymed.2010.08.002
Wan, 2013, Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry, J. Chromatogr. A, 1286, 83, 10.1016/j.chroma.2013.02.053
Wang, 2011, The screening toolbox of bioactive substances from natural products: a review, Fitoterapia, 82, 1141, 10.1016/j.fitote.2011.08.007
Wang, 2011, Metabolic engineering of flavonoids in plants and microorganisms, Appl. Microbiol. Biotechnol., 91, 949, 10.1007/s00253-011-3449-2
Wang, 2013, TALEN-mediated editing of the mouse Y chromosome, Nat. Biotechnol., 31, 530, 10.1038/nbt.2595
Wang, 2013, A novel strategy to evaluate the quality of traditional Chinese medicine based on the correlation analysis of chemical fingerprint and biological effect, J. Pharm. Biomed. Anal., 83, 57, 10.1016/j.jpba.2013.04.035
Wang, 2014, Investigation of antioxidant interactions between Radix astragali and Cimicifuga foetida and identification of synergistic antioxidant compounds, PLoS One, 9, e87221, 10.1371/journal.pone.0087221
Wang, 2014, Transformation of ginsenosides from notoginseng by artificial gastric juice can increase cytotoxicity toward cancer cells, J. Agric. Food Chem., 62, 2558, 10.1021/jf405482s
Wang, 2014, Genetic screens in human cells using the CRISPR-Cas9 system, Science, 343, 80, 10.1126/science.1246981
Wani, 1971, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J. Am. Chem. Soc., 93, 2325, 10.1021/ja00738a045
Waszkowycz, 2011, Outstanding challenges in protein-ligand docking and structure-based virtual screening, Wiley Interdiscip. Rev.: Comput. Mol. Sci., 1, 229
Wawrosch, 2005, In vitro cultivation of medicinal plants, 261
Wawrosch, 2010, In vitro propagation of medicinal plants for conservation and quality assurance, 93
Wawrosch, 2014, Lignan formation in hairy root cultures of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter), Fitoterapia, 97, 219, 10.1016/j.fitote.2014.06.008
Weathers, 2010, Bench to batch: advances in plant cell culture for producing useful products, Appl. Microbiol. Biotechnol., 85, 1339, 10.1007/s00253-009-2354-4
Wei, 2011, Total synthesis of solamargine, Bioorg. Med. Chem. Lett., 21, 2930, 10.1016/j.bmcl.2011.03.064
Wei, 2011, Antioxidant condensed tannins from Machilus pauhoi leaves, J. Med. Plant Res., 5, 796
Wenzel, 2005, Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways, Curr. Opin. Biotechnol., 16, 594, 10.1016/j.copbio.2005.10.001
Werner, 2010, Short chemoenzymic azide-free synthesis of oseltamivir (Tamiflu): approaching the potential for process efficiency, Adv. Synth. Catal., 352, 195, 10.1002/adsc.200900844
White, 2008, Qinghaosu (artemisinin): the price of success, Science, 320, 330, 10.1126/science.1155165
WHO, 2003
Wiedenfeld, 2007, Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida, Pharmazie, 62, 308
Wiesrum, 2006, Cultivation of medicinal plants as a tool for biodiversity conservation and poverty alleviation in the Amatola Region, South Africa, 43
Wilson, 2012, Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules, Plant Biotechnol. J., 10, 249, 10.1111/j.1467-7652.2011.00664.x
Wilson, 2014, Metabolic engineering approaches for production of biochemicals in food and medicinal plants, Curr. Opin. Biotechnol., 26, 174, 10.1016/j.copbio.2014.01.006
Wolber, 2013, Virtual screening and target fishing for natural products using 3D pharmacophores, 117
Wolfender, 2013, Plant metabolomics: from holistic data to relevant biomarkers, Curr. Med. Chem., 20, 1056
Wolfender, 2014, Current approaches and challenges for the metabolite profiling of complex natural extracts, J. Chromatogr. A
Wood, 2011, Targeted genome editing across species using ZFNs and TALENs, Science, 333, 307, 10.1126/science.1207773
Xiao, 2013, Metabolism of dietary flavonoids in liver microsomes, Curr. Drug Metab., 14, 381, 10.2174/1389200211314040003
Xiao, 2007, Polyisoprenylated benzoylphloroglucinol derivatives from Hypericum sampsonii, J. Nat. Prod., 70, 1779, 10.1021/np0704147
Xie, 2011, Phenolic acids are in vivo atheroprotective compounds appearing in the serum of rats after blueberry consumption, J. Agric. Food Chem., 59, 10381, 10.1021/jf2025264
Xie, 2014, Activity-guided isolation of NF-kappaB inhibitors and PPARgamma agonists from the root bark of Lycium chinense Miller, J. Ethnopharmacol., 152, 470, 10.1016/j.jep.2014.01.029
Yu, 2014, Utility of hesperidinase for food function research: enzymatic digestion of botanical extracts alters cellular antioxidant capacities and anti-inflammatory properties, J. Agric. Food Chem., 62, 8640, 10.1021/jf501963a
Yuan, 1991, Studies on the antifertility components from Marsdenia koi, J. Tongji Med. Univ., 11, 165, 10.1007/BF02888129
Yuliana, 2011, Metabolomics for bioactivity assessment of natural products, Phytother. Res., 25, 157, 10.1002/ptr.3258
Yun, 2012, Plant natural products: history, limitations and the potential of cambial meristematic cells, Biotechnol. Genet. Eng. Rev., 28, 47, 10.5661/bger-28-47
Zaman, 2003, Fluorescence assays for high-throughput screening of protein kinases, Comb. Chem. High Throughput Screen., 6, 313, 10.2174/138620703106298563
Zambrowicz, 2003, Knockouts model the 100 best-selling drugs — will they model the next 100?, Nat. Rev. Drug Discov., 2, 38, 10.1038/nrd987
Zenk, 2007, Evolution and current status of the phytochemistry of nitrogenous compounds, Phytochemistry, 68, 2757, 10.1016/j.phytochem.2007.07.009
Zhang, 2001, Antimalarial compounds from Rhaphidophora decursiva, J. Nat. Prod., 64, 772, 10.1021/np010037c
Zhang, 2010, Condensed tannins from mangrove species Kandelia candel and Rhizophora mangle and their antioxidant activity, Molecules, 15, 420, 10.3390/molecules15010420
Zhang, 2011, Molecular determinants of magnolol targeting both RXRalpha and PPARgamma, PLoS One, 6, e28253, 10.1371/journal.pone.0028253
Zhang, 2012, Preclinical experimental models of drug metabolism and disposition in drug discovery and development, Acta Pharm. Sin. B, 2, 549, 10.1016/j.apsb.2012.10.004
Zhao, 2005, Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases, J. Med. Chem., 48, 3463, 10.1021/jm0490538
Zhao, 2005, Elicitor signal transduction leading to production of plant secondary metabolites, Biotechnol. Adv., 23, 283, 10.1016/j.biotechadv.2005.01.003
Zheng, 2013, Phenotypic screens as a renewed approach for drug discovery, Drug Discov. Today, 18, 1067, 10.1016/j.drudis.2013.07.001
Zhou, 2014, Novel fermentation processes for manufacturing plant natural products, Curr. Opin. Biotechnol., 25, 17, 10.1016/j.copbio.2013.08.009
Zhu, 1998, Chinese Materia Medica, 1
Zhu, 1997, Plant polyphenols: biologically active compounds or non-selective binders to protein?, Phytochemistry, 44, 441, 10.1016/S0031-9422(96)00598-5
Zhu, 2013, Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins, Curr. Med. Chem., 20, 840
Ziegler, 2013, Target identification for small bioactive molecules: finding the needle in the haystack, Angew. Chem. Int. Ed. Engl., 52, 2744, 10.1002/anie.201208749
Zimmermann, 2007, Multi-target therapeutics: when the whole is greater than the sum of the parts, Drug Discov. Today, 12, 34, 10.1016/j.drudis.2006.11.008